{
    "2020-03-19": [
        [
            {
                "time": "2023-10-18",
                "original_text": "J&J Files NDA for Multiple Sclerosis Drug Ponesimod in U.S.",
                "features": {
                    "keywords": [
                        "J&J",
                        "NDA",
                        "Multiple Sclerosis",
                        "Ponesimod"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-18",
                "original_text": "The Daily Biotech Pulse: Pfizer's Eczema Drug Aces Latestage Study, Orphan Drug Designation For Dicerna, Dyadic's COVID-19 Connection",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "eczema drug",
                        "latestage study",
                        "orphan drug designation",
                        "Dicerna",
                        "Dyadic",
                        "COVID-19"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "biotechnology",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}